Media Summary: If you're a person living with metastatic breast cancer ( In this interview, William Gradishar, MD, Northwestern University Feinberg School of During this session, learn what personalized

Information About A Treatment For Mbc - Detailed Analysis & Overview

If you're a person living with metastatic breast cancer ( In this interview, William Gradishar, MD, Northwestern University Feinberg School of During this session, learn what personalized Clinical trials determine whether new approaches to breast cancer care are safer and more effective than those used today. Hear from Eleonora Teplinsky, MD about the most recent drug approvals in metastatic breast cancer and how they impact each ... Dr. Diana Lake, Medical Oncologist, Memorial Sloan Kettering Cancer Center, explains the basics of metastatic breast cancer ...

This session covers what's coming next in Whether this is your first breast cancer diagnosis, or you have had breast cancer before, learning you have metastatic breast ... In this episode, Dr. Adrienne Waks from the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute shares ... Receiving a metastatic breast cancer diagnosis is overwhelming, but understanding what happens next can make a big difference ... An overview of the evolution of first-line HER2-positive breast cancer is aggressive, but research and clinical trials have transformed it from one of the most difficult to treat ...

Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss advances in research and Watch this virtually recorded event where Dr. Parsons of Dana-Farber Cancer Institute delves into her incredible work on ...

Photo Gallery

Information About a Treatment for mBC
Dr. Gradishar on Managing Toxicities and Tailoring Treatment in HER2+ mBC
Personalized medicine in MBC: what it means for you
Navigating Breast Cancer Treatment Options - Yale Medicine Explains
MBC Clinical Trials : An Introduction
Medical updates in MBC: What you need to know
Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist
MBC 101: What Happens Now?
Seattle Patient Education Event - The Future of MBC Stage IV Treatment
Newly diagnosed: A guide for understanding a diagnosis of MBC
MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research & Treatment Landscape
HER2 Positive mBC Emerging Treatment Landscape
View Detailed Profile
Information About a Treatment for mBC

Information About a Treatment for mBC

If you're a person living with metastatic breast cancer (

Dr. Gradishar on Managing Toxicities and Tailoring Treatment in HER2+ mBC

Dr. Gradishar on Managing Toxicities and Tailoring Treatment in HER2+ mBC

In this interview, William Gradishar, MD, Northwestern University Feinberg School of

Personalized medicine in MBC: what it means for you

Personalized medicine in MBC: what it means for you

During this session, learn what personalized

Navigating Breast Cancer Treatment Options - Yale Medicine Explains

Navigating Breast Cancer Treatment Options - Yale Medicine Explains

For more

MBC Clinical Trials : An Introduction

MBC Clinical Trials : An Introduction

Clinical trials determine whether new approaches to breast cancer care are safer and more effective than those used today.

Medical updates in MBC: What you need to know

Medical updates in MBC: What you need to know

Hear from Eleonora Teplinsky, MD about the most recent drug approvals in metastatic breast cancer and how they impact each ...

Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist

Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist

Optimizing metastatic breast cancer

MBC 101: What Happens Now?

MBC 101: What Happens Now?

Dr. Diana Lake, Medical Oncologist, Memorial Sloan Kettering Cancer Center, explains the basics of metastatic breast cancer ...

Seattle Patient Education Event - The Future of MBC Stage IV Treatment

Seattle Patient Education Event - The Future of MBC Stage IV Treatment

This session covers what's coming next in

Newly diagnosed: A guide for understanding a diagnosis of MBC

Newly diagnosed: A guide for understanding a diagnosis of MBC

Whether this is your first breast cancer diagnosis, or you have had breast cancer before, learning you have metastatic breast ...

MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research & Treatment Landscape

MBC Impact Series: HER2-positive Metastatic Breast Cancer - 2025 Research & Treatment Landscape

In this episode, Dr. Adrienne Waks from the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute shares ...

HER2 Positive mBC Emerging Treatment Landscape

HER2 Positive mBC Emerging Treatment Landscape

An expert in the

Starting Metastatic Breast Cancer Treatment: What to Expect & How to Prepare

Starting Metastatic Breast Cancer Treatment: What to Expect & How to Prepare

Receiving a metastatic breast cancer diagnosis is overwhelming, but understanding what happens next can make a big difference ...

Quick Guide to Treatment for Metastatic Breast Cancer

Quick Guide to Treatment for Metastatic Breast Cancer

This video covers

The Evolution of Treatment Approaches for ER+ MBC

The Evolution of Treatment Approaches for ER+ MBC

An overview of the evolution of first-line

MBC Treatment

MBC Treatment

MBC Treatment

Breast Cancer Breakthroughs Episode 17: What's New in Metastatic HER2+ Breast Cancer?

Breast Cancer Breakthroughs Episode 17: What's New in Metastatic HER2+ Breast Cancer?

HER2-positive breast cancer is aggressive, but research and clinical trials have transformed it from one of the most difficult to treat ...

Metastatic Breast Cancer Post-CDK4/6 Inhibitor HR+ HER2- Treatment Guide

Metastatic Breast Cancer Post-CDK4/6 Inhibitor HR+ HER2- Treatment Guide

In-Depth Article: https://oncologytube.com/post-cdk4-6-inhibitor-

HER2 Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019

HER2 Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019

Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss advances in research and

MBC Impact Series: Metastatic HER2+ Breast Cancer

MBC Impact Series: Metastatic HER2+ Breast Cancer

Watch this virtually recorded event where Dr. Parsons of Dana-Farber Cancer Institute delves into her incredible work on ...